Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-040762
Filing Date
2015-05-08
Accepted
2015-05-08 18:45:59
Documents
2
Period of Report
2015-05-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4185
2 EX-24 DOCUMENT attachment1.htm EX-24 3983
  Complete submission text file 0001209191-15-040762.txt   10494
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Issuer) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE BAXTER PARKWAY DEERFIELD IL 60015
Business Address ONE BAXTER PARKWAY DEERFIELD IL 60015 224-948-2000
Baxalta Inc (Reporting) CIK: 0001620546 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36020 | Film No.: 15848266
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BAXALTA INC. ONE BAXTER PARKWAY DEEFIELD IL 60615
Business Address C/O BAXALTA INC. ONE BAXTER PARKWAY DEEFIELD IL 60615 224-948-2000
Baxalta GmbH (Reporting) CIK: 0001640387 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36020 | Film No.: 15848267